Cargando…
A case study of the utilization of clozapine treatment for treatment‐resistant schizophrenia associated with 22q11.2 deletion syndrome
BACKGROUND: The optimal treatment strategy for patients with treatment‐resistant schizophrenia (TRS) associated with 22q11.2 deletion syndrome (DS) remains a subject of debate. CASE PRESENTATION: We present the case of a 40‐year‐old female patient diagnosed with TRS and 22q11.2DS who was effectively...
Autores principales: | Tsurue, Arisa, Funahashi, Hideki, Tsurue, Keiichi, Kawano, Masahiko, Ishida, Yasushi, Hirano, Yoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275284/ https://www.ncbi.nlm.nih.gov/pubmed/36929244 http://dx.doi.org/10.1002/npr2.12333 |
Ejemplares similares
-
Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder
por: Borders, Candace B., et al.
Publicado: (2017) -
Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome
por: Heung, Tracy, et al.
Publicado: (2022) -
Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome
por: Bassett, Anne S., et al.
Publicado: (2008) -
miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome
por: Brzustowicz, Linda M., et al.
Publicado: (2012) -
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
por: Cleynen, Isabelle, et al.
Publicado: (2020)